Jun 19, 2020
Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma
Apr 14, 2020
AVM Biotechnology has FDA Approval for Clinical Trials for Promising New Cancer Treatment
Apr 01, 2020
GenScript Launches Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development
Jan 27, 2020
Biotech Brief: Demand is Growing for Safer, More-Efficacious Drugs When Treating Pancreatic Cancer
Dec 09, 2019
Publication of First In-Human Data Reveals Safety & Efficacy of Tigilanol Tiglate in Solid Tumours
Dec 08, 2019
Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies
Jul 10, 2019
Syndax Pharmaceuticals Announces FDA Clearance of IND Application for Targeted Menin Inhibitor SNDX-5613 for Relapsed/Refractory Acute Leukemias
Jun 27, 2019
CB-839 (Calithera Biosciences) Drug Overview 2019: CB-839 will be the First Glutaminase Inhibitor Approved for the Treatment of Renal Cell Carcinoma
Mar 20, 2019
Lymphoma Research Foundation Announces More Than 20 Lymphoma and Chronic Lymphocytic Leukemia Research Grants
Mar 12, 2019
OncoTracker Expands Multiple Myeloma Intellectual Property
Apr 12, 2018
Trovagene Announces Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2018
Apr 10, 2018
ProMIS Neurosciences Announces Publication of Peer Reviewed Scientific Paper Describing a Novel Target on Toxic Oligomers of Amyloid Beta in Alzheimer's Disease
Mar 15, 2018
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer
Jan 25, 2018
ProMIS Neurosciences Issues White Paper Entitled: "Not All Amyloid Beta Therapeutics Are Created Equal"
Nov 21, 2017
Theravance Biopharma to Present at Two Upcoming Investor Conferences
Oct 17, 2017
Syndax Expands Pipeline with Exclusive Worldwide License to Allergan's Portfolio of Menin-MLL Inhibitors
Sep 19, 2017
Theravance Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 05, 2017
Theravance Biopharma to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
Jul 26, 2017
Frost & Sullivan Acclaims CGI's Advanced Genomic & Biomarker Technologies That Drive Industry Innovation in Support of Precision Cancer Treatment
Jun 23, 2017
EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe